Log in
Enquire now
‌

US Patent 11840516 KCNQ potentiators

Patent 11840516 was granted and assigned to Eli Lilly and Company on December, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Eli Lilly
Eli Lilly
0
Current Assignee
Eli Lilly
Eli Lilly
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
118405160
Patent Inventor Names
Maria Ann Whatton0
Andrew Caerwyn Williams0
Helen Jane Szekeres0
Date of Patent
December 12, 2023
0
Patent Application Number
175310000
Date Filed
November 19, 2021
0
Patent Citations
‌
US Patent 11208383 KCNQ potentiators
0
Patent Primary Examiner
‌
Timothy R Rozof
0
CPC Code
‌
A61P 25/28
0
‌
C07D 213/64
0
‌
C07D 213/38
0
Patent abstract

Small molecule potentiatiors to potassium channels (such as Kv7 potentiators—which are also called KCNQ potentiators), compositions including such compounds, and methods of using such compounds for the treatment of Amyotrophic Lateral Sclerosis and other neurological diseases caused by changes in motor neuron excitability, including, but not limited to, primary lateral sclerosis, pseudobulbar palsy, progressive bulbar palsy, progressive muscular atrophy and epilepsy.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11840516 KCNQ potentiators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.